NATCO Pharma Limited (NSE:NATCOPHARM)
India · Delayed Price · Currency is INR 955.85
-60.35 (-5.94%)
At close: Mar 13, 2026
NATCO Pharma Market Cap
NATCO Pharma has a market cap or net worth of 171.2 billion as of March 13, 2026. Its market cap has increased by 17.57% in one year.
Market Cap
171.20B
Enterprise Value
141.81B
Revenue
45.63B
Ranking
n/a
PE Ratio
10.99
Stock Price
955.85
Market Cap Chart
Since March 31, 1999, NATCO Pharma's market cap has increased from 429.39M to 171.20B, an increase of 39,771.16%. That is a compound annual growth rate of 24.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 182.01B | 12.53% |
| Dec 31, 2025 | 161.75B | -34.91% |
| Dec 31, 2024 | 248.48B | 70.99% |
| Dec 29, 2023 | 145.32B | 41.73% |
| Dec 30, 2022 | 102.53B | -37.85% |
| Dec 31, 2021 | 164.98B | -5.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ipca Laboratories | 378.32B |
| Ajanta Pharma | 374.65B |
| Emcure Pharmaceuticals | 297.24B |
| Gland Pharma | 278.14B |
| Wockhardt | 215.69B |
| Piramal Pharma | 206.31B |
| Eris Lifesciences | 187.16B |
| Alembic Pharmaceuticals | 140.02B |